Grace Therapeutics
GRCE
12 hedge funds and large institutions have $914K invested in Grace Therapeutics in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
38% less capital invested
Capital invested by funds: $1.48M → $914K (-$565K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$16.8K |
| 2 |
Renaissance Technologies
New York
|
+$15.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.06K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$705 |
| 5 |
Citigroup
New York
|
+$313 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$10.3K |
| 2 |
EWM
Edge Wealth Management
New York
|
-$1K |
| 3 |
CS
Credential Securities
Vancouver,
|
-$27 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $360K | – | – | – |
|
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $311K | -$10.3K | -132 | -3% |
|
|
IIM
3
Intact Investment Management
Montreal,
Quebec, Canada
| $173K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $46K | +$15.5K | +198 | +46% |
|
|
5
Jane Street
New York
| $16K | +$16.8K | +215 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $5K | +$3.06K | +39 | +108% |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1K | +$705 | +9 | +225% |
|
|
EWM
10
Edge Wealth Management
New York
| – | -$1K | -3 | Closed |
|
|
CS
11
Credential Securities
Vancouver,
| – | -$27 | – | – |
|
|
12
Citigroup
New York
| – | +$313 | +4 | +400% |
|
13
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$313 | +4 | New |
|
GRCE Hedge Fund Activity: Q1 2016 in Review
12 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q1 2016, worth a combined $914K — down 38% from $1.48M a quarter earlier.
Fund positioning in GRCE was balanced in Q1 2016: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $16.8K. The largest seller was Bank of Montreal, cutting an estimated $10.3K.
- 12 institutional investors held Grace Therapeutics (GRCE) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $914K of Grace Therapeutics stock for Q1 2016, down 38% quarter-over-quarter.
- 2 funds opened new Grace Therapeutics positions in Q1 2016 and 2 closed out, a net change of 0 holders.
- The largest Grace Therapeutics buyer in Q1 2016 was Jane Street, an estimated $16.8K added.
- The largest Grace Therapeutics seller in Q1 2016 was Bank of Montreal, an estimated $10.3K sold.
Based on aggregated 13F filings for Q1 2016.